bicalutamide has been researched along with Cancer of Ovary in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aghajanian, C; Derosa, F; Esch, J; Hensley, M; Iasonos, A; Juretzka, M; Konner, J; Levine, D; Lewin, S; Park, K; Sabbatini, P; Spriggs, D | 1 |
1 trial(s) available for bicalutamide and Cancer of Ovary
Article | Year |
---|---|
A phase II evaluation of goserelin and bicalutamide in patients with ovarian cancer in second or higher complete clinical disease remission.
Topics: Adult; Aged; Androgen Antagonists; Anilides; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Female; Goserelin; Humans; Middle Aged; Neoplasm Recurrence, Local; Nitriles; Ovarian Neoplasms; Tosyl Compounds | 2007 |